Pure Biologics Spólka Akcyjna (PUR.WA)

PLN 9.19

(-3.26%)

Revenue Summary of Pure Biologics Spólka Akcyjna

Pure Biologics Spólka Akcyjna's latest annual revenue in 2023 was 95 Thousand PLN , down -85.65% from previous year.
Pure Biologics Spólka Akcyjna's latest quarterly revenue in 2024 Q2 was -3000.00 PLN , down -200.0% from previous quarter.
Pure Biologics Spólka Akcyjna reported a annual revenue of 662 Thousand PLN in annual revenue 2022, up 160.63% from previous year.
Pure Biologics Spólka Akcyjna reported a annual revenue of 254 Thousand PLN in annual revenue 2021, down -55.59% from previous year.
Pure Biologics Spólka Akcyjna reported a quarterly revenue of 3000.00 PLN for 2024 Q1, down -66.67% from previous quarter.
Pure Biologics Spólka Akcyjna reported a quarterly revenue of 56 Thousand PLN for 2023 Q3, up 5500.0% from previous quarter.

Annual Revenue Chart of Pure Biologics Spólka Akcyjna (2023 - 2016)

Historical Annual Revenue of Pure Biologics Spólka Akcyjna (2023 - 2016)

Year	Revenue	Revenue Growth
2023	95 Thousand PLN	-85.65%
2022	662 Thousand PLN	160.63%
2021	254 Thousand PLN	-55.59%
2020	572 Thousand PLN	-96.59%
2019	16.75 Million PLN	75.75%
2018	9.53 Million PLN	870.83%
2017	981.83 Thousand PLN	-23.82%
2016	1.28 Million PLN	0.0%

Year	Revenue	Revenue Growth
2024 Q2	-3000.00 PLN	-200.0%
2024 Q1	3000.00 PLN	-66.67%
2023 Q3	56 Thousand PLN	5500.0%
2023 Q4	9000.00 PLN	-83.93%
2023 Q1	29 Thousand PLN	26.09%
2023 Q2	1000.00 PLN	-96.55%
2023 FY	95 Thousand PLN	-85.65%
2022 Q2	262 Thousand PLN	129.82%
2022 Q4	23 Thousand PLN	-91.25%
2022 FY	662 Thousand PLN	160.63%
2022 Q1	114 Thousand PLN	9.62%
2022 Q3	263 Thousand PLN	0.38%
2021 Q1	2000.00 PLN	-93.1%
2021 FY	254 Thousand PLN	-55.59%
2021 Q3	82 Thousand PLN	26.15%
2021 Q4	104 Thousand PLN	26.83%
2021 Q2	65 Thousand PLN	3150.0%
2020 Q4	29 Thousand PLN	-75.0%
2020 FY	572 Thousand PLN	-96.59%
2020 Q2	94 Thousand PLN	-97.89%
2020 Q3	116 Thousand PLN	23.4%
2020 Q1	4.45 Million PLN	-9.12%
2019 Q2	3.88 Million PLN	6.19%
2019 Q1	3.65 Million PLN	-10.37%
2019 FY	16.75 Million PLN	75.75%
2019 Q4	4.9 Million PLN	14.07%
2019 Q3	4.3 Million PLN	10.75%
2018 Q3	2.42 Million PLN	44.32%
2018 FY	9.53 Million PLN	870.83%
2018 Q1	1.34 Million PLN	234.18%
2018 Q2	1.68 Million PLN	24.85%
2018 Q4	4.08 Million PLN	68.34%
2017 Q3	269.51 Thousand PLN	0.0%
2017 FY	981.83 Thousand PLN	-23.82%
2017 Q4	402.67 Thousand PLN	49.41%
2016 FY	1.28 Million PLN	0.0%

Peer Revenue Comparison of Pure Biologics Spólka Akcyjna

Name	Revenue	Revenue Difference
Bioceltix S.A.	- PLN	-Infinity%
BIOTON S.A.	181.63 Million PLN	99.948%
Captor Therapeutics Spolka Akcyjna	13.2 Million PLN	99.28%
Mabion S.A.	151.67 Million PLN	99.937%
Molecure S.A.	100.00 PLN	-94900.0%
NanoGroup S.A.	2019.00 PLN	-4605.3%
Pharmena S.A.	9.83 Million PLN	99.034%
Poltreg S.A.	1.39 Million PLN	93.209%
Ryvu Therapeutics S.A.	46.86 Million PLN	99.797%
Synthaverse S.A.	58.6 Million PLN	99.838%
Urteste S.A.	- PLN	-Infinity%